Skip to main content
$3.07 $0.07 (2.3%)

04:00 PM EST on 11/29/21

DBV Technologies S.A. (NASDAQ:DBVT)

CAPS Rating: 1 out of 5

Current Price $3.07 Mkt Cap $288.6M
Open $3.11 P/E Ratio 0.00
Prev. Close $3.07 Div. (Yield) $0.00 (0.0%)
Daily Range $3.01 - $3.11 Volume 40,593
52-Wk Range $2.33 - $7.38 Avg. Daily Vol. 390,919

Caps

How do you think NASDAQ:DBVT will perform against the market?

Add Stock to CAPS Watchlist

All Players

13 Outperform
3 Underperform
 

All-Star Players

4 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:DBVT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

MarkBiotech (< 20)
Submitted March 07, 2018

although viaskin didn't reach its PE of efficacy, the responder rates were still significant over placebo. There were no concerning TEAE's.. Viaskin's strong safety profile is what will put patients preference over AIMT's Ar101. AR101 experienced a… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:DBVT VS S&P 500 (SPY)

NASDAQ:DBVT Summary

Fools bullish on NASDAQ:DBVT are also bullish on:

Fools bearish on NASDAQ:DBVT are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about DBVT.

Recs

0
Member Avatar TMFSecurity (79.28) Submitted: 11/16/2021 9:59:49 AM : Underperform Start Price: $3.10 NASDAQ:DBVT Score: +0.05

10000000146

Recs

1
Member Avatar MarkBiotech (< 20) Submitted: 3/7/2018 3:41:31 PM : Outperform Start Price: $22.21 NASDAQ:DBVT Score: -157.10

although viaskin didn't reach its PE of efficacy, the responder rates were still significant over placebo. There were no concerning TEAE's.. Viaskin's strong safety profile is what will put patients preference over AIMT's Ar101. AR101 experienced a 12.4% discontinuation rate due to TEAE's meanwhile viaskin TEAE DR, was 1.1%. At the EOD, the patients are what matters the most. a risk of anaphylaxis is not something a parent will gamble with.. safety will always be the top priority when it comes to the parents choice for their kids. For that reason.. i'm going to go with viaskin as the SOC for peanut allergy resistance over AR101. Viaskin is also applicable in many other allergies including milk, nuts, egg.. Viaskin expansion of indications could easily put sales over 1b or a price of 100 PPS. PT-100.

Recs

1
Member Avatar stationfool (76.72) Submitted: 6/23/2015 1:09:32 PM : Outperform Start Price: $33.72 NASDAQ:DBVT Score: -219.04

Peanut Allergy Drug

Leaderboard

Find the members with the highest scoring picks in DBVT.

Score Leader

Bigcaps19

Bigcaps19 (34.06) Score: +132.69

The Score Leader is the player with the highest score across all their picks in DBVT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
DyingClub < 20 8/3/2020 Underperform 5Y $4.34 -29.26% +41.49% +70.75 0 Comment
Kinzo 99.82 2/2/2021 Underperform 5Y $5.54 -44.58% +21.26% +65.84 0 Comment
Narbly 22.92 10/2/2020 Outperform 5Y $1.72 +78.49% +40.06% +38.43 0 Comment
TMFSecurity 79.28 11/16/2021 Underperform NS $3.10 -0.97% -0.92% +0.05 1 Comment
TSIF 99.98 3/17/2020 Outperform 1Y $2.20 +39.55% +95.03% -55.49 0 Comment
vchelimella < 20 5/29/2020 Outperform 5Y $4.84 -36.57% +53.83% -90.40 0 Comment
Toprope101 99.35 5/6/2020 Outperform 5Y $5.96 -48.49% +61.46% -109.95 0 Comment
cashfoolery 55.12 1/31/2020 Outperform 5Y $10.40 -70.48% +42.30% -112.78 0 Comment
portefeuille 98.17 4/29/2019 Outperform 5Y $10.34 -70.31% +58.26% -128.57 0 Comment
northcutt0 < 20 12/21/2018 Outperform 5Y $5.50 -44.18% +88.27% -132.45 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for DBVT.